Biogen Idec's 'Plegridy' therapy for multiple sclerosis delayed by FDA

Home › Biogen Idec's 'Plegridy' therapy for multiple sclerosis delayed by FDA

Two new multiple sclerosis pills have hit the market and a third is on the way to replace shots with potentially serious side effects.

23.11
23.11	NEXT
23.11
23.11	(Rawlings)
23.11	DVD2
23.11
23.11	US Orig LP The Soul Searchers Salt Of ~
23.11	Switch SR SL LED 2
More »

je.st